Advertisement

Topics

. @TakedaPharma Sells Two Drugs for $5.7B+, Licenses a Third, in Deals Aimed at Refocusing Pipeline: http://ow.ly/sROm50u58Fj pic.twitter.com/2KzGzM17hL

13:25 EDT 12 May 2019 | Genetic Engineering News

. Sells Two Drugs for $5.7B+, Licenses a Third, in Deals Aimed at Refocusing Pipeline: http://ow.ly/sROm50u58Fj 

Original Article: . @TakedaPharma Sells Two Drugs for $5.7B+, Licenses a Third, in Deals Aimed at Refocusing Pipeline: http://ow.ly/sROm50u58Fj pic.twitter.com/2KzGzM17hL

NEXT ARTICLE

More From BioPortfolio on ". @TakedaPharma Sells Two Drugs for $5.7B+, Licenses a Third, in Deals Aimed at Refocusing Pipeline: http://ow.ly/sROm50u58Fj pic.twitter.com/2KzGzM17hL"

Advertisement
Quick Search
Advertisement
Advertisement